INTI

Inhibitor Therapeutics, Inc.

OTC· Pharmaceutical Preparations· Inc. DE· CIK 0001042418 Biotech & Drug Discovery

$0.0611 −0.01 (−13.94%)

Oct 26 4:00 PM ET · prev $0.0710

Next earnings

Nov 11

in 16 days

1 year

+22.2%

from $0.0500 · Oct 27

30 days

−38.9%

from $0.1000

52-week range

$0.0400–0.1240

−51% from high · low Dec 11

Avg volume 20D

7.2K

Oct 26 spike 90.0K

Short interest

4.6K

0.0%

Days to cover

1.0

at average volume

Insider net

no open-market trades · 12 mo

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

X Jun 15 Short interest falls 33.9% to 11.8K
X Jun 30 Short interest falls 60.6% to 4.6K

Signal stack

Where each data set points today.

InsidersNO TRADES

No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
Short sellersSTEADY

Short interest 0.0% to 4.6K shares. 1.0 days to cover.
TrendDOWNTREND

32% below its 50-day average.

Recent activity

The latest filings, insider trades, analyst actions, press and options flow — newest first.

Aug 11, 2026 Earnings calendar

INTI Q2 2026 Earnings Scheduled — 2026-08-11

Jul 1, 2026 Insider

Black Robe Capital LLC gifted 3,200,000 shares

Chief Financial Officer

May 5, 2026 Insider

Vasisht Niraj was granted 50,000 shares

Director

May 4, 2026 Insider

OSMAN RONALD E was granted 50,000 shares

Director

Insider ledger

Form 4

open-market buys or sells · 12 mo

Date	Insider	Type	Value
Jul 1, 2026	Black Robe Capital LLC Chief Financial Officer	GIFT	3,200,000 sh
May 5, 2026	Vasisht Niraj Director	AWARD	50,000 sh
May 4, 2026	OSMAN RONALD E Director	AWARD	50,000 sh
May 4, 2026	Yanez Michelle Director	AWARD	50,000 sh
May 4, 2026	SEARS SAMUEL P JR Director	AWARD	50,000 sh
May 4, 2026	ODONNELL FRANCIS E JR Chief Executive Officer	AWARD	50,000 sh
May 4, 2026	Jerman Michael Allen Director	AWARD	50,000 sh